Literature DB >> 21429762

Mineralocorticoid receptors in the brain and cardiovascular regulation: minority rule?

Elise P Gomez-Sanchez1.   

Abstract

A small proportion of brain mineralocorticoid receptors (MR) mediate control of blood pressure, water and electrolyte balance, sodium appetite, and sympathetic drive to the periphery. Circulating inflammatory cytokines modulate MR-mediated changes in sympathoexcitation. Aldosterone binding to MR in the brain occurs, despite concentrations that are 2-3 orders of magnitude less than those of cortisol and corticosterone, which have similar affinity for the MR. The possible mechanisms for selective MR activation by aldosterone, the cellular mechanisms of MR action and the effects of brain MR on hemodynamic homeostasis are considered in this review. MR antagonists are valuable adjuncts to the treatment of chronic cardiovascular and renal disease; the crucial need to discover targets for development of selective therapy for specific MR functions is also discussed. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21429762      PMCID: PMC3140534          DOI: 10.1016/j.tem.2011.02.001

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  101 in total

Review 1.  Central nervous system and mechanisms of hypertension.

Authors:  M J Brody
Journal:  Clin Physiol Biochem       Date:  1988

2.  Endogenous aldosterone and corticosterone in brain cell nuclei of adrenal-intact rats: regional distribution and effects of physiological variations in serum steroids.

Authors:  B G Yongue; E J Roy
Journal:  Brain Res       Date:  1987-12-08       Impact factor: 3.252

3.  Hormone and blood pressure relationships in primary aldosteronism.

Authors:  M G Nicholls; E A Espiner; H Ikram; A H Maslowski; E J Hamilton; P J Bones
Journal:  Clin Exp Hypertens A       Date:  1984

4.  Nuclear localization of aldosterone in rat brain cells assessed by autoradiography.

Authors:  M K Birmingham; W E Stumpf; M Sar
Journal:  Experientia       Date:  1979-09-15

5.  Aldosterone blocks the response to corticosterone in the raphe-hippocampal serotonin system.

Authors:  E R De Kloet; D H Versteeg; G L Kovacs
Journal:  Brain Res       Date:  1983-04-04       Impact factor: 3.252

6.  Neural regulation of the proinflammatory cytokine response to acute myocardial infarction.

Authors:  Joseph Francis; Zhi-Hua Zhang; Robert M Weiss; Robert B Felder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-08       Impact factor: 4.733

7.  Dose-response studies of intracerebroventricular infusion of aldosterone in sensitized and non-sensitized rats.

Authors:  E P Gomez Sanchez
Journal:  J Hypertens       Date:  1988-06       Impact factor: 4.844

8.  The influence of heart rate on the secretion of a substance closely resembling the 18-monoacetate of D-aldosterone by the hearts of cats under chloralose anaesthesia.

Authors:  M F Lockett; R W Retallack
Journal:  J Physiol       Date:  1970-05       Impact factor: 5.182

9.  Increased sympathetic activity in renovascular hypertension in man.

Authors:  R D Gordon; A W Bachmann; R V Jackson; N Saar
Journal:  Clin Exp Pharmacol Physiol       Date:  1982 May-Jun       Impact factor: 2.557

10.  Significance of sodium, sympathetic innervation, and central adrenergic structures on renal vascular responsiveness in DOCA-treated rats.

Authors:  K H Berecek; R D Murray; F Gross
Journal:  Circ Res       Date:  1980-11       Impact factor: 17.367

View more
  8 in total

1.  Plasma metabolite biomarkers predictive of radiation induced cardiotoxicity.

Authors:  Keith Unger; Yaoxiang Li; Celine Yeh; Ana Barac; Monvadi B Srichai; Elizabeth A Ballew; Michael Girgis; Meth Jayatilake; Vijayalakshmi Sridharan; Marjan Boerma; Amrita K Cheema
Journal:  Radiother Oncol       Date:  2020-04-20       Impact factor: 6.280

2.  Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and Schizophrenia.

Authors:  Harald Murck; Thomas Laughren; Femke Lamers; Rosalind Picard; Sebastian Walther; Donald Goff; Stephen Sainati
Journal:  Innov Clin Neurosci       Date:  2015 Mar-Apr

Review 3.  Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

Authors:  Juan M Saavedra
Journal:  Clin Sci (Lond)       Date:  2012-11       Impact factor: 6.124

Review 4.  Genetic Approaches to Hypothalamic-Pituitary-Adrenal Axis Regulation.

Authors:  Melinda G Arnett; Lisa M Muglia; Gloria Laryea; Louis J Muglia
Journal:  Neuropsychopharmacology       Date:  2015-07-20       Impact factor: 7.853

5.  Stimulation of aldosterone synthesis by angiotensin II in the brain: support for positive feedback in hypertension?

Authors:  Deborah A Scheuer
Journal:  Hypertension       Date:  2013-07-15       Impact factor: 10.190

Review 6.  Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?

Authors:  Xin Du; Terence Y Pang
Journal:  Front Psychiatry       Date:  2015-03-09       Impact factor: 4.157

7.  Aldosterone and the mineralocorticoid receptor in the cerebral circulation and stroke.

Authors:  Quynh N Dinh; Thiruma V Arumugam; Morag J Young; Grant R Drummond; Christopher G Sobey; Sophocles Chrissobolis
Journal:  Exp Transl Stroke Med       Date:  2012-10-30

8.  Mineralocorticoid receptor signaling reduces numbers of circulating human naïve T cells and increases their CD62L, CCR7, and CXCR4 expression.

Authors:  Luciana Besedovsky; Barbara Linz; Jan Born; Tanja Lange
Journal:  Eur J Immunol       Date:  2014-04-10       Impact factor: 5.532

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.